{"id":"W3089665196","doi":"10.1182/bloodadvances.2020002621","title":"Comparison of outcomes of HCT in blast phase of <i>BCR-ABL1</i>− MPN with de novo AML and with AML following MDS","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Janssen Pharmaceuticals; National Institute of Allergy and Infectious Diseases; Daiichi Sankyo Europe; National Cancer Institute; Office of Naval Research; Legend Biotech; Kite Pharma; Sanofi Genzyme; Takeda Oncology; Health Resources and Services Administration; bluebird bio; Kiadis Pharma; Swedish Orphan Biovitrum; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Atara Biotherapeutics; Actinium Pharmaceuticals; National Institutes of Health; Regeneron Pharmaceuticals; Medical College of Wisconsin; Janssen Biotech; HistoGenetics; U.S. Department of Defense; Sanofi; GlaxoSmithKline; U.S. Navy; Celgene; CSL Behring; Bristol-Myers Squibb; Terumo BCT; AstraZeneca; Astellas Pharma US; Biomedical Advanced Research and Development Authority; Amgen; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Medac; Jazz Pharmaceuticals; Be The Match Foundation","keywords":"Hazard ratio; Internal medicine; Medicine; Myeloid leukemia; Oncology; Myelodysplastic syndromes; Proportional hazards model; Transplantation; Confidence interval; Myeloid; Leukemia; International Prognostic Scoring System; Gastroenterology; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001623974,0.0001695122,0.0008976692,0.0001225065,0.00002036994,0.000004543881,0.0001335825,0.00004951569,0.00001174351],"category_scores_gemma":[0.0001650355,0.0001160812,0.00005684935,0.000460883,0.0002418143,0.0001515699,0.00005674634,0.0002317063,4.747134e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002531177,"about_ca_system_score_gemma":0.000242991,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009656817,"about_ca_topic_score_gemma":0.0001583511,"domain_scores_codex":[0.9985763,0.00004360993,0.0004188667,0.0002521021,0.0004403833,0.0002687757],"domain_scores_gemma":[0.9991497,0.0002036719,0.0002093769,0.0002001946,0.0000884669,0.0001485206],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001576449,0.0006800801,0.9394823,0.0006386514,0.0002728332,0.0001217102,0.001683413,0.0001461327,0.05300819,0.00002718525,0.00002216524,0.002340843],"study_design_scores_gemma":[0.05188804,0.01325827,0.1452643,0.00148127,0.0008840517,0.00008673488,0.008051909,0.001320205,0.7759442,0.00002946973,0.001376197,0.0004153916],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961506,0.001962605,0.0003407323,0.0005552863,0.00001053818,0.0003647084,0.0000212078,0.00001694667,0.0005773412],"genre_scores_gemma":[0.9900393,0.0001127414,0.009634375,0.0001108658,0.00002258087,0.00001187174,0.000007404228,0.00002380739,0.00003697721],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7942181,"threshold_uncertainty_score":0.4733654,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02924001898230542,"score_gpt":0.3656019217454994,"score_spread":0.336361902763194,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}